Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
EditForce, a Japan-based creator of DNA and RNA drug development technology, raised $4.5m in funding yesterday from structural wood members manufacturer Yoshimei, MP Healthcare Venture Management and FFG Venture Investment. The commitment is an extension to the $7.3m round led by Newton Biocapital in May 2021, when University of Tokyo Edge Capital (UTEC), Itochu Technology Ventures, a subsidiary of trading group Itochu, telecoms firm KDDI and Global Brain also invested. UTEC and Itochu Technology Ventures contributed to an $7.8m…
